A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy

BACKGROUND: Neurokinin (NK) 1 receptor antagonists (RAs), administered in combination with a 5‐hydroxytryptamine‐3 (5‐HT(3)) RA and dexamethasone (DEX), have demonstrated clear improvements in chemotherapy‐induced nausea and vomiting (CINV) prevention over a 5‐HT(3)RA plus DEX. However, studies comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zelek, Laurent, Debourdeau, Philippe, Bourgeois, Hugues, Wagner, Jean Philippe, Brocard, Fabien, Lefeuvre‐Plesse, Claudia, Chauffert, Bruno, Leheurteur, Marianne, Bachet, Jean‐Baptiste, Simon, Hélène, Mayeur, Didier, Scotté, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488783/
https://www.ncbi.nlm.nih.gov/pubmed/34216177
http://dx.doi.org/10.1002/onco.13888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488783/
https://www.ncbi.nlm.nih.gov/pubmed/34216177
http://dx.doi.org/10.1002/onco.13888

Ejemplares similares